Bleakley Financial Group LLC Has $1.30 Million Holdings in Cardinal Health, Inc. (NYSE:CAH)

Bleakley Financial Group LLC increased its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 144.6% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 10,998 shares of the company's stock after buying an additional 6,501 shares during the quarter. Bleakley Financial Group LLC's holdings in Cardinal Health were worth $1,301,000 at the end of the most recent quarter.

A number of other institutional investors have also added to or reduced their stakes in CAH. Eastern Bank acquired a new stake in shares of Cardinal Health in the 3rd quarter valued at $25,000. Frazier Financial Advisors LLC raised its holdings in shares of Cardinal Health by 69.8% in the third quarter. Frazier Financial Advisors LLC now owns 253 shares of the company's stock valued at $28,000 after buying an additional 104 shares during the last quarter. Hara Capital LLC bought a new position in shares of Cardinal Health in the third quarter valued at about $31,000. AM Squared Ltd bought a new position in shares of Cardinal Health in the third quarter valued at about $33,000. Finally, Carolina Wealth Advisors LLC bought a new position in shares of Cardinal Health in the third quarter valued at about $47,000. 87.17% of the stock is owned by institutional investors and hedge funds.

Cardinal Health Stock Down 1.0 %

Shares of CAH traded down $1.30 on Wednesday, hitting $127.09. The company's stock had a trading volume of 2,771,646 shares, compared to its average volume of 2,388,005. The firm's fifty day moving average price is $122.66 and its 200-day moving average price is $115.83. Cardinal Health, Inc. has a fifty-two week low of $93.17 and a fifty-two week high of $132.84. The firm has a market capitalization of $30.70 billion, a price-to-earnings ratio of 23.71, a P/E/G ratio of 1.49 and a beta of 0.63.

Cardinal Health (NYSE:CAH - Get Free Report) last issued its quarterly earnings data on Thursday, January 30th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.74 by $0.19. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. As a group, equities analysts predict that Cardinal Health, Inc. will post 7.95 earnings per share for the current fiscal year.

Cardinal Health Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be given a dividend of $0.5056 per share. This represents a $2.02 dividend on an annualized basis and a yield of 1.59%. The ex-dividend date is Tuesday, April 1st. Cardinal Health's dividend payout ratio (DPR) is currently 37.69%.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CAH. JPMorgan Chase & Co. lifted their price target on Cardinal Health from $142.00 to $145.00 and gave the company a "neutral" rating in a report on Tuesday, February 4th. Barclays lifted their price target on Cardinal Health from $117.00 to $133.00 and gave the company an "overweight" rating in a report on Monday, November 4th. Bank of America raised Cardinal Health from a "neutral" rating to a "buy" rating and lifted their price target for the company from $132.00 to $145.00 in a report on Monday, January 6th. Wells Fargo & Company boosted their price objective on Cardinal Health from $135.00 to $136.00 and gave the stock an "equal weight" rating in a report on Tuesday, February 4th. Finally, StockNews.com cut Cardinal Health from a "strong-buy" rating to a "buy" rating in a report on Sunday, November 3rd. Four research analysts have rated the stock with a hold rating and thirteen have given a buy rating to the company's stock. According to MarketBeat.com, Cardinal Health has an average rating of "Moderate Buy" and a consensus price target of $136.87.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.